Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | KDM2B | Q8NHM5 | 10/20 | 0.34 |
| ▸ | DHFR | P00374 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23075907 | 0.82 | POLB (0.39) | ADRA2CLMNA | |
| SCHEMBL9803211 | 0.81 | SIGMAR1 (0.60) | ADRA2CSIGMAR1ALDH1A1LMNAMAPT | |
| SCHEMBL29312032 | 0.78 | HTR3A (0.40) | SIGMAR1ALDH1A1KDM2B | |
| SCHEMBL29312041 | 0.77 | PDK2 (0.34) | — | |
| SCHEMBL29312037 | 0.76 | OPRM1 (0.32) | SIGMAR1ALDH1A1LMNAMAPTSMN1; SMN2 | |
| SCHEMBL15221262 | 0.75 | SIGMAR1 (0.53) | ADRA2CSIGMAR1ALDH1A1LMNAMAPT | |
| SCHEMBL29312040 | 0.75 | PDK2 (0.41) | — | |
| SCHEMBL29312033 | 0.75 | PDK2 (0.41) | — | |
| SCHEMBL29274507 | 0.75 | PDK2 (0.41) | — | |
| SCHEMBL29312039 | 0.74 | NOS1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240237526-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240237526-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, AND ELECTRONIC DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240237526-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, AND ELECTRONIC DEVICE | CHRM1, CYP1A1, HAX1 | ADRA2C 914/4885SIGMAR1 17/4885ALDH1A1 237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.